Actymthera
1 known investors
Actym develops engineered bacterial therapeutics for cancer and fibrotic disease treatment, using a proprietary STACT™ platform based on Salmonella typhimurium as a delivery vehicle for localized therapeutic payloads.
BiotechDigital HealthMedical Devices